|
All patients
n=1233
|
Dupilumab
n=631
|
Other systemics
n=107
|
Limited/no treatment
n=495
|
Severity |
|
|
|
|
0 (n, %) |
947 (77%) |
492 (78%) |
73 (68%) |
382
(77%) |
1 (n, %) |
204 (16%) |
110 (17%) |
18 (17%) |
76
(15%) |
2 (n,%) |
78 (6%) |
29 (5%) |
15 (14%) |
34 (7%) |
3 (n,%) |
4 (0.3%) |
0 (0%) |
1 (1%) |
3 (1%) |
4/5 (n, %) |
0 (0%) |
0 (0%) |
0 (0%) |
0 (0%) |